Document is current
Any future updates will be listed below
-
Authors
Simone, Simona https://orcid.org/0000-0002-2569-3558
Pronzo, Virginia https://orcid.org/0000-0002-3955-6319
Pesce, Francesco https://orcid.org/0000-0002-2882-4226
Bavaro, Davide Fiore https://orcid.org/0000-0002-4833-7118
Infante, Barbara https://orcid.org/0000-0003-1815-5361
Mercuri, Silvia
Schirinzi, Annalisa https://orcid.org/0000-0001-9826-7907
Panaro, Antonella https://orcid.org/0000-0002-8409-4870
Conte, Eleonora https://orcid.org/0009-0000-3986-3178
Belati, Alessandra https://orcid.org/0000-0001-5455-8964
Troise, Dario https://orcid.org/0000-0003-2648-6021
Pontrelli, Paola https://orcid.org/0000-0002-7654-8318
Conserva, Francesca https://orcid.org/0000-0003-2863-864X
Gallo, Pasquale https://orcid.org/0000-0001-8914-2600
Panico, Maddalena
Spilotros, Marco https://orcid.org/0000-0003-1237-3018
Lucarelli, Giuseppe https://orcid.org/0000-0001-7807-1229
Saracino, Annalisa https://orcid.org/0000-0001-9558-208X
Stallone, Giovanni https://orcid.org/0000-0002-2862-9017
Di Serio, Francesca https://orcid.org/0000-0001-6089-1165
Ditonno, Pasquale https://orcid.org/0000-0001-7718-7676
Gesualdo, Loreto https://orcid.org/0000-0002-4861-0911
-
Funding
Funding for this research was provided by:
Università degli Studi di Bari Aldo Moro
- License Information
-
More Information
Article History
Received: 18 April 2023
Accepted: 5 January 2024
First Online: 23 May 2024
Declarations
:
: LG received fees from FRESENIUS, ESTOR, WERFEN, ASTELLAS, ASTRAZENECA, TRAVERE, SANDOZ, SANOFI, BAXTER, MUNDIPHARMA, ESTOR, PHARMADOC, RETROPHIN, TRAVERE, ASTRAZENECA, GSK, NOVARTIS, CHINOOK, ROCHE, MEDTRONIC for activities of invited speaker and consultant.
: The Local Ethics Committees approved the study protocol (study n°6845, prot. n°0050551).
: Written informed consent was obtained before enrolment.
